NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $971,936 | -10.8% | 50,569 | +18.0% | 0.03% | +3.7% |
Q2 2023 | $1,089,628 | -17.7% | 42,865 | +17.1% | 0.03% | -25.0% |
Q1 2023 | $1,323,560 | +4.1% | 36,613 | +14.1% | 0.04% | 0.0% |
Q4 2022 | $1,271,239 | -12.4% | 32,102 | +3.0% | 0.04% | -25.0% |
Q3 2022 | $1,452,000 | +5.2% | 31,166 | -1.0% | 0.05% | +20.0% |
Q2 2022 | $1,380,000 | -29.0% | 31,495 | +17.1% | 0.04% | +2.6% |
Q1 2022 | $1,945,000 | -12.8% | 26,894 | -2.3% | 0.04% | -9.3% |
Q4 2021 | $2,231,000 | -20.7% | 27,525 | +13.9% | 0.04% | -40.3% |
Q3 2021 | $2,812,000 | -7.0% | 24,162 | +32.5% | 0.07% | -25.0% |
Q2 2021 | $3,023,000 | +32.0% | 18,231 | +11.1% | 0.10% | +11.6% |
Q1 2021 | $2,290,000 | +45.7% | 16,414 | +80.7% | 0.09% | +17.8% |
Q4 2020 | $1,572,000 | +172.9% | 9,082 | +119.7% | 0.07% | +121.2% |
Q3 2020 | $576,000 | +93.3% | 4,133 | +65.9% | 0.03% | -32.7% |
Q2 2020 | $298,000 | +183.8% | 2,491 | +137.2% | 0.05% | -14.0% |
Q1 2020 | $105,000 | +26.5% | 1,050 | +48.7% | 0.06% | +235.3% |
Q4 2019 | $83,000 | – | 706 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,192,298 | $47,215,001 | 1.58% |
Altium Capital Management LP | 76,000 | $3,009,600 | 1.53% |
Rock Springs Capital Management LP | 1,077,900 | $42,684,840 | 1.03% |
Integral Health Asset Management, LLC | 109,000 | $4,316,400 | 0.91% |
ArrowMark Colorado Holdings LLC | 1,252,218 | $49,587,833 | 0.59% |
FOX RUN MANAGEMENT, L.L.C. | 26,963 | $1,067,735 | 0.43% |
PDT Partners, LLC | 55,715 | $2,206,314 | 0.36% |
FRED ALGER MANAGEMENT, LLC | 1,184,000 | $46,886,400 | 0.25% |
Dynamic Technology Lab Private Ltd | 62,819 | $2,488 | 0.25% |
K2 PRINCIPAL FUND, L.P. | 38,000 | $1,504,800 | 0.23% |